Hims & Hers Health, Inc.
For the period ended Jun 30, 2025. Filed Aug 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 4, 2025
HIMS$19.13-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In Thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities | ||
| Net income | $91,990 | $24,425 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 18,741 | 6,644 |
| Stock-based compensation | 60,584 | 43,074 |
| Net accretion on securities | (1,060) | (2,281) |
| Benefit for deferred taxes | (10,346) | — |
| Impairment of long-lived assets | — | 114 |
| Amortization of debt discount and issuance costs | 1,047 | — |
| Non-cash operating lease cost | 4,594 | 1,221 |
| Non-cash acquisition-related costs | 2,985 | — |
| Non-cash other | (1,315) | 412 |
| Changes in operating assets and liabilities: | ||
| Inventory | (77,373) | (18,124) |
| Prepaid expenses and other current assets | (38,081) | (1,430) |
| Other long-term assets | (10) | (47) |
| Accounts payable | 5,146 | 16,156 |
| Accrued liabilities | 11,737 | (24) |
| Deferred revenue | 23,132 | 13,257 |
| Operating lease liabilities | (1,798) | (1,140) |
| Earn-out payable | — | (2,825) |
| Net cash provided by operating activities | 89,973 | 79,432 |
| Investing activities | ||
| Purchases of investments | — | (97,539) |
| Maturities of investments | 60,569 | 126,095 |
| Investment in website development and internal-use software | (7,961) | (6,191) |
| Purchases of property, equipment, and intangible assets | (101,392) | (13,793) |
| Acquisition of business, net of cash acquired | (5,100) | — |
| Net cash (used in) provided by investing activities | (53,884) | 8,572 |
| Financing activities | ||
| Proceeds from issuance of convertible senior notes, net of debt discount | 970,000 | — |
| Purchases of capped calls related to convertible senior notes | (47,800) | — |
| Proceeds from exercise of vested stock options | 6,497 | 16,472 |
| Payments for taxes related to net share settlement of equity awards | (62,475) | (22,281) |
| Proceeds from employee stock purchase plan | 2,970 | 1,622 |
| Payments for debt issuance costs | (3,041) | — |
| Repurchases of common stock | — | (47,996) |
| Payments for acquisition-related earn-out consideration | — | (3,190) |
| Net cash provided by (used in) financing activities | 866,151 | (55,373) |
| Foreign currency effect on cash and cash equivalents | 1,270 | 1 |
| Increase in cash, cash equivalents, and restricted cash | 903,510 | 32,632 |
| Cash, cash equivalents, and restricted cash at beginning of period | 221,440 | 97,519 |
| Cash, cash equivalents, and restricted cash at end of period | $1,124,950 | $130,151 |
| Reconciliation of cash, cash equivalents, and restricted cash | ||
| Cash and cash equivalents | $1,124,582 | $129,295 |
| Restricted cash | 368 | 856 |
| Total cash, cash equivalents, and restricted cash | $1,124,950 | $130,151 |
| Supplemental disclosures of cash flow information | ||
| Cash paid for taxes | $23,047 | $3,468 |
| Non-cash investing and financing activities | ||
| Purchases of property and equipment included in accounts payable and accrued liabilities | $16,954 | $1,256 |
| Deferred debt issuance costs included in accounts payable and accrued liabilities | 249 | — |
| Right-of-use asset obtained in exchange for lease liability | 63,434 | 2,174 |
| Issuance of common stock in connection with asset acquisition | 12,760 | — |
| Common stock to be issued for asset acquisition indemnification holdback | 6,380 | — |
| Issuance of common stock for acquisition-related earn-out consideration | — | 1,396 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.